HK1039333A1 - 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders - Google Patents

3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders

Info

Publication number
HK1039333A1
HK1039333A1 HK02100870A HK02100870A HK1039333A1 HK 1039333 A1 HK1039333 A1 HK 1039333A1 HK 02100870 A HK02100870 A HK 02100870A HK 02100870 A HK02100870 A HK 02100870A HK 1039333 A1 HK1039333 A1 HK 1039333A1
Authority
HK
Hong Kong
Prior art keywords
tetrahydropyridin
indoles
treatment
psychotic disorders
psychotic
Prior art date
Application number
HK02100870A
Other languages
English (en)
Inventor
Martinus T M Tulp
Heijden Johannes A M Van Der
Bernard Van Vliet
Jacobus Tipker
Roelof Van Hes
Cornelis G Kruse
Gerben M Visser
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of HK1039333A1 publication Critical patent/HK1039333A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK02100870A 1998-10-16 2002-02-05 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders HK1039333A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203499 1998-10-16
PCT/EP1999/007912 WO2000023441A1 (en) 1998-10-16 1999-10-15 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders

Publications (1)

Publication Number Publication Date
HK1039333A1 true HK1039333A1 (en) 2002-04-19

Family

ID=8234230

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100870A HK1039333A1 (en) 1998-10-16 2002-02-05 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders

Country Status (29)

Country Link
US (1) US6391896B1 (no)
EP (1) EP1121356B1 (no)
JP (1) JP4659984B2 (no)
KR (1) KR100619464B1 (no)
CN (1) CN1140524C (no)
AR (1) AR020773A1 (no)
AT (1) ATE230741T1 (no)
AU (1) AU750811B2 (no)
BR (1) BR9914582A (no)
CA (1) CA2346896C (no)
CZ (1) CZ20011353A3 (no)
DE (1) DE69904849T2 (no)
DK (1) DK1121356T3 (no)
DZ (1) DZ2917A1 (no)
ES (1) ES2188260T3 (no)
HK (1) HK1039333A1 (no)
HU (1) HUP0104701A3 (no)
IL (2) IL142589A0 (no)
NO (1) NO320531B1 (no)
NZ (1) NZ511289A (no)
PL (1) PL195734B1 (no)
RU (1) RU2222535C2 (no)
SI (1) SI1121356T1 (no)
SK (1) SK285764B6 (no)
TR (1) TR200101808T2 (no)
TW (1) TW577884B (no)
UA (1) UA66888C2 (no)
WO (1) WO2000023441A1 (no)
ZA (1) ZA200103251B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373855A1 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
SK287018B6 (sk) 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
AR032711A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene
AR032712A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
US8101619B2 (en) 2004-12-08 2012-01-24 Solvay Pharmaceuticals B.V. Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
US9709700B2 (en) * 2005-04-06 2017-07-18 3M Innovative Properties Company Optical bodies including rough strippable boundary layers
ATE411161T1 (de) 2005-04-06 2008-10-15 3M Innovative Properties Co Optische körper mit rauen abziehbaren grenzschichten und asymmetrischen oberflächenstrukturen
US20060227421A1 (en) * 2005-04-06 2006-10-12 Stover Carl A Optical bodies including strippable boundary layers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
JP2002527515A (ja) 2002-08-27
HUP0104701A3 (en) 2003-01-28
IL142589A (en) 2007-10-31
NO320531B1 (no) 2005-12-19
KR100619464B1 (ko) 2006-09-05
NO20011892L (no) 2001-06-12
HUP0104701A2 (hu) 2002-04-29
DK1121356T3 (da) 2003-03-24
CA2346896A1 (en) 2000-04-27
BR9914582A (pt) 2001-07-03
JP4659984B2 (ja) 2011-03-30
ZA200103251B (en) 2002-07-22
PL347329A1 (en) 2002-03-25
SK5122001A3 (en) 2001-10-08
ES2188260T3 (es) 2003-06-16
IL142589A0 (en) 2002-03-10
SI1121356T1 (en) 2003-04-30
PL195734B1 (pl) 2007-10-31
CA2346896C (en) 2008-12-09
TW577884B (en) 2004-03-01
WO2000023441A1 (en) 2000-04-27
CN1328553A (zh) 2001-12-26
NO20011892D0 (no) 2001-04-17
US6391896B1 (en) 2002-05-21
RU2222535C2 (ru) 2004-01-27
CN1140524C (zh) 2004-03-03
EP1121356B1 (en) 2003-01-08
AR020773A1 (es) 2002-05-29
AU750811B2 (en) 2002-07-25
DZ2917A1 (fr) 2004-06-20
NZ511289A (en) 2003-01-31
DE69904849T2 (de) 2003-11-13
TR200101808T2 (tr) 2001-10-22
AU6474199A (en) 2000-05-08
KR20010080183A (ko) 2001-08-22
CZ20011353A3 (cs) 2001-09-12
SK285764B6 (sk) 2007-07-06
UA66888C2 (uk) 2004-06-15
EP1121356A1 (en) 2001-08-08
ATE230741T1 (de) 2003-01-15
DE69904849D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
HRP990195B1 (en) Intranasal formulations for the treatment of sexual disorders
IL138129A (en) Composition for therapy of estrogen-associated disorders
IL143979A0 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
IL141263A0 (en) Methods for treatment of neurological disorders
HK1044944A1 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AU2001271706A1 (en) Use of substituted indole compounds for treating breast disorders
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
PL347329A1 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders
AU4552200A (en) Method of treating psychotic disorders
AU7388101A (en) Indole derivatives useful for the treatment of cns disorders
IL140540A0 (en) Treatment of anxiety disorders
IL153605A0 (en) Indole derivatives useful for the treatment of cns disorders
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
IL153254A0 (en) Indole derivatives useful for the treatment of cns disorders
PL343596A1 (en) Paroxetine 10-camphorsulfonate for treatment of cns disorders
AU7521598A (en) Aralkoxy-morphinan derivatives for treatment of cns disorders
IL153234A0 (en) Indole derivatives useful for the treatment of cns disorders
IL153351A0 (en) Indole derivatives useful for the treatment of cns disorders
SI1294710T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1305307T1 (en) Indole derivatives useful for the treatment of cns disorders
SI1049670T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
SI1049672T1 (en) Azetidinecarboxamide derivatives for treating cns disorders
GB9821610D0 (en) Treatment of neuropsychiatric disorders
SI0914321T1 (en) Indole derivatives for the treatment of osteoporosis
SI1147083T1 (en) Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111015